313 related articles for article (PubMed ID: 23280141)
1. Effects of acetazolamide on cognitive performance during high-altitude exposure.
Wang J; Ke T; Zhang X; Chen Y; Liu M; Chen J; Luo W
Neurotoxicol Teratol; 2013; 35():28-33. PubMed ID: 23280141
[TBL] [Abstract][Full Text] [Related]
2. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
[TBL] [Abstract][Full Text] [Related]
3. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
Phillips L; Basnyat B; Chang Y; Swenson ER; Harris NS
High Alt Med Biol; 2017 Jun; 18(2):121-127. PubMed ID: 28509579
[TBL] [Abstract][Full Text] [Related]
4. Exercise limitation of acetazolamide at altitude (3459 m).
Bradwell AR; Myers SD; Beazley M; Ashdown K; Harris NG; Bradwell SB; Goodhart J; Imray CH; Wimalasena Y; Edsell ME; Pattinson KT; Wright AD; Harris SJ;
Wilderness Environ Med; 2014 Sep; 25(3):272-7. PubMed ID: 24931587
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment of acute mountain sickness and acetazolamide.
White AJ
Aviat Space Environ Med; 1984 Jul; 55(7):598-603. PubMed ID: 6466255
[TBL] [Abstract][Full Text] [Related]
7. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure is not associated with acute mountain sickness.
Cushing T; Paterson R; Haukoos J; Harris NS
High Alt Med Biol; 2013 Dec; 14(4):342-5. PubMed ID: 24377341
[TBL] [Abstract][Full Text] [Related]
9. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
[TBL] [Abstract][Full Text] [Related]
11. The effect of acetazolamide on saccadic latency at 3459 meters.
Faull OK; Robertson J; Thomas O; Bradwell AR; Antoniades CA; Pattinson KT;
Wilderness Environ Med; 2015 Mar; 26(1):72-7. PubMed ID: 25712298
[TBL] [Abstract][Full Text] [Related]
12. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis.
Kayser B; Dumont L; Lysakowski C; Combescure C; Haller G; Tramèr MR
High Alt Med Biol; 2012 Jun; 13(2):82-92. PubMed ID: 22724610
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C
High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
[TBL] [Abstract][Full Text] [Related]
14. Acute mountain sickness impact among travelers to Cusco, Peru.
Salazar H; Swanson J; Mozo K; White AC; Cabada MM
J Travel Med; 2012 Jul; 19(4):220-5. PubMed ID: 22776382
[TBL] [Abstract][Full Text] [Related]
15. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
Carlsten C; Swenson ER; Ruoss S
High Alt Med Biol; 2004; 5(1):33-9. PubMed ID: 15072715
[TBL] [Abstract][Full Text] [Related]
16. Altitude, Acute Mountain Sickness, and Acetazolamide: Recommendations for Rapid Ascent.
Toussaint CM; Kenefick RW; Petrassi FA; Muza SR; Charkoudian N
High Alt Med Biol; 2021 Mar; 22(1):5-13. PubMed ID: 32975448
[TBL] [Abstract][Full Text] [Related]
17. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
Davies AJ; Kalson NS; Stokes S; Earl MD; Whitehead AG; Frost H; Tyrell-Marsh I; Naylor J
Wilderness Environ Med; 2009; 20(4):311-7. PubMed ID: 20030437
[TBL] [Abstract][Full Text] [Related]
18. Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide.
Burns P; Lipman GS; Warner K; Jurkiewicz C; Phillips C; Sanders L; Soto M; Hackett P
Am J Med; 2019 Feb; 132(2):247-251. PubMed ID: 30419226
[TBL] [Abstract][Full Text] [Related]
19. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
Bernhard WN; Schalick LM; Delaney PA; Bernhard TM; Barnas GM
Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
[TBL] [Abstract][Full Text] [Related]
20. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults.
Furian M; Mademilov M; Buergin A; Scheiwiller PM; Mayer L; Schneider S; Emilov B; Lichtblau M; Bitos K; Muralt L; Groth A; Reiser AE; Sevik A; Sheraliev U; Marazhapov NH; Aydaralieva S; Muratbekova A; Tabyshova A; Abdraeva A; Buenzli S; Sooronbaev TM; Ulrich S; Bloch KE
NEJM Evid; 2022 Jan; 1(1):EVIDoa2100006. PubMed ID: 38296630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
